Now showing items 1-1 of 1

    • Expanded Safety Experience with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma 

      Chen, Christine; Reece, Donna E; Niesvizky, Ruben; Boccia, Ralph V; Stadtmauer, Edward A; Abonour, Rafat; Matous, Jeffrey; Kumar, Shaji; Bahlis, Nizar J; Alsina, Melissa; Vescio, Robert; Coutre, Steven E; Pietronigro, Dennis; Knight, Robert D; Zeldis, Jerome B; Rajkumar, Vincent; Siegel, David; Richardson, Paul Gerard Guy (Blackwell Publishing Ltd, 2009)
      Lenalidomide gained Food and Drug Administration (FDA) approval for treatment of patients with relapsed or refractory multiple myeloma (MM) in combination with dexamethasone in June 2006. In April 2005, the FDA and patient ...